1. Home
  2. PODD vs IP Comparison

PODD vs IP Comparison

Compare PODD & IP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • IP
  • Stock Information
  • Founded
  • PODD 2000
  • IP 1898
  • Country
  • PODD United States
  • IP United States
  • Employees
  • PODD N/A
  • IP N/A
  • Industry
  • PODD Medical/Dental Instruments
  • IP Paper
  • Sector
  • PODD Health Care
  • IP Basic Materials
  • Exchange
  • PODD Nasdaq
  • IP Nasdaq
  • Market Cap
  • PODD 16.5B
  • IP 19.4B
  • IPO Year
  • PODD 2007
  • IP N/A
  • Fundamental
  • Price
  • PODD $261.71
  • IP $54.66
  • Analyst Decision
  • PODD Buy
  • IP Strong Buy
  • Analyst Count
  • PODD 16
  • IP 9
  • Target Price
  • PODD $265.81
  • IP $52.08
  • AVG Volume (30 Days)
  • PODD 528.9K
  • IP 3.6M
  • Earning Date
  • PODD 11-07-2024
  • IP 01-30-2025
  • Dividend Yield
  • PODD N/A
  • IP 3.31%
  • EPS Growth
  • PODD 235.68
  • IP 65.41
  • EPS
  • PODD 5.74
  • IP 1.18
  • Revenue
  • PODD $1,983,900,000.00
  • IP $18,640,000,000.00
  • Revenue This Year
  • PODD $23.56
  • IP $2.36
  • Revenue Next Year
  • PODD $18.07
  • IP $4.58
  • P/E Ratio
  • PODD $45.91
  • IP $46.88
  • Revenue Growth
  • PODD 27.42
  • IP N/A
  • 52 Week Low
  • PODD $160.19
  • IP $32.70
  • 52 Week High
  • PODD $279.77
  • IP $60.36
  • Technical
  • Relative Strength Index (RSI)
  • PODD 46.07
  • IP 45.91
  • Support Level
  • PODD $258.96
  • IP $53.86
  • Resistance Level
  • PODD $279.77
  • IP $56.14
  • Average True Range (ATR)
  • PODD 6.52
  • IP 0.94
  • MACD
  • PODD -1.90
  • IP -0.47
  • Stochastic Oscillator
  • PODD 4.61
  • IP 29.49

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

About IP International Paper Company

International Paper manufactures packaging products and cellulose fibers. It accounts for roughly one third of the North American corrugated packaging market. Though it has operations in Brazil, India, and China, more than three fourths of its sales come from North America. International Paper serves a variety of end markets, including industrial, consumer products, and manufacturing.

Share on Social Networks: